Chengzhi Co., Ltd. (SHE:000990)
China · Delayed Price · Currency is CNY 10.67
+0.09 (0.85%)
Apr 17, 2026, 3:05 PM CST
Chengzhi Market Cap
Chengzhi has a market cap or net worth of 12.97 billion as of April 17, 2026. Its market cap has increased by 39.48% in one year.
Market Cap
12.97B
Enterprise Value
16.80B
Revenue
10.87B
Ranking
n/a
PE Ratio
183.31
Stock Price
10.67
Market Cap Chart
Since January 2, 2001, Chengzhi's market cap has increased from 4.51B to 12.97B, an increase of 187.74%. That is a compound annual growth rate of 4.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 12.97B | 34.72% |
| Dec 31, 2025 | 9.62B | 2.19% |
| Dec 31, 2024 | 9.42B | -5.60% |
| Dec 29, 2023 | 9.98B | -6.70% |
| Dec 30, 2022 | 10.69B | -44.37% |
| Dec 31, 2021 | 19.23B | 33.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Staidson (Beijing) BioPharmaceuticals | 14.49B |
| Tibet Cheezheng Tibetan Medicine | 13.27B |
| Vcanbio Cell & Gene Engineering Corp., | 12.91B |
| InventisBio | 12.76B |
| Pacific Shuanglin Bio-pharmacy | 12.27B |
| Hualan Biological Vaccine | 11.85B |
| Chengdu Olymvax Biopharmaceuticals | 11.81B |
| Chengdu Easton Biopharmaceuticals | 11.66B |